starting to build, page-9

Like most long term holders (about 10 years for me) I was very pleased when the board brought in Stewart Washer as CEO. I was quite concerned when he left and had some exchange with the board over his departure.

While no one would go into details, understandably, I have been assured that his departure had nothing to do with any s=differences over the direction of the company or over commercializing the company's IP. The chairman offered to set up a phone call with Washer, but I did not take this up.

The fact is that both operating divisions (Polynovo and Metabolic) operate fairly independently from each other and both are headed by very competent men in Laurent Fossaert and David Kenley.

I'm not worried, but I'd sure like to see the announcement of patient recruitment for the BTM trials.